Anonymous
Guest
Anonymous
Guest
Just heard that Chuck Heinz just up and left the company after 3 years leading the sarilumab team. Is this true? Cause if it is, that team is in trouble.
Rob Livesay certainly isn't bringing anything to market successfully
That's not what I hear about Livesay, he is not a "good guy", he pretends to be. Actually he is in way over his head and is Bob Terifay's puppet. But again, this is hearsay, not sure how much is true.
Sarilumab is a joke. Regeneron cannot compete with Genentech. Period.